Search Results

Showing 2 from 2 results

Teva's Dr Andrew Ellis elected Chair of the British Biosimilars Association
Teva UK Limited has welcomed the election of Dr Andrew Ellis, Director of Secondary Care at Teva UK, to the position of Chair of the British Biosimilars Association (BBA).

Biopharmaceuticals at Teva
Discover why Teva is investing in biopharmaceuticals and their potential to help patients around the world.
Date of preparation: August 2021
Reference: COB-GB-NP-00062